Related references
Note: Only part of the references are listed.GDF15 mediates the effects of metformin on body weight and energy balance
Anthony P. Coll et al.
NATURE (2020)
GDF15: A Hormone Conveying Somatic Distress to the Brain
Samuel M. Lockhart et al.
ENDOCRINE REVIEWS (2020)
Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases
Seung Joon Baek et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
Shiu Lun Au Yeung et al.
DIABETOLOGIA (2019)
Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort
Xue Bao et al.
DIABETOLOGIA (2019)
Effect of bariatric surgery on plasma GDF15 in humans
Maximilian Kleinert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert et al.
CLINICAL CHEMISTRY (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson et al.
NATURE MEDICINE (2017)
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure Insights From the HF-ACTION Study
Abhinav Sharma et al.
JACC-HEART FAILURE (2017)
Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study)
David W. Schopfer et al.
AMERICAN HEART JOURNAL (2014)
Biomarkers of Cardiovascular Stress and Subclinical Atherosclerosis in the Community
Deepa M. Gopal et al.
CLINICAL CHEMISTRY (2014)
NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
K. Chrysovergis et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T Assay
M. Odette Gore et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
Anand Rohatgi et al.
CLINICAL CHEMISTRY (2012)
Clinical and Genetic Correlates of Growth Differentiation Factor 15 in the Community
Jennifer E. Ho et al.
CLINICAL CHEMISTRY (2012)
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
Tibor Kempf et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support
Sjoukje I. Lok et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction
Rajalakshmi Santhanakrishnan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults The Rancho Bernardo Study
Lori B. Daniels et al.
CIRCULATION (2011)
The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients
Greisa Vila et al.
CLINICAL CHEMISTRY (2011)
Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial
Inder S. Anand et al.
CIRCULATION (2010)
Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study
Maren Carstensen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
Raoul Stahrenberg et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease Results From the AtheroGene Study
Tibor Kempf et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human Adipocytes
Qi Ding et al.
ENDOCRINOLOGY (2009)
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
Lars Lind et al.
EUROPEAN HEART JOURNAL (2009)
Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet
Ivana Dostalova et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
A crucial role for adipose tissue p53 in the regulation of insulin resistance
Tohru Minamino et al.
NATURE MEDICINE (2009)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
JL Januzzi et al.
EUROPEAN HEART JOURNAL (2006)
Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
D Schlittenhardt et al.
CELL AND TISSUE RESEARCH (2004)
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
DA Brown et al.
LANCET (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
